Two Sigma Investments, LP Cara Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

  • $40.3 Billion
  • Q1 2024

A detailed history of Two Sigma Investments, LP transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 277,978 shares of CARA stock, worth $91,732. This represents 0.0% of its overall portfolio holdings.

Number of Shares
277,978
Previous 307,271 9.53%
Holding current value
$91,732
Previous $227,000 11.01%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.52 - $1.05 $15,232 - $30,757
-29,293 Reduced 9.53%
277,978 $252,000
Q4 2023

Feb 14, 2024
BUY
$0.6 - $1.65 $142,499 - $391,873
237,499 Added 340.39%
307,271 $227,000
Q3 2023

Nov 14, 2023
SELL
$1.67 - $3.33 $283,422 - $565,147
-169,714 Reduced 70.87%
69,772 $117,000
Q2 2023

Aug 14, 2023
BUY
$2.83 - $4.94 $214,372 - $374,205
75,750 Added 46.26%
239,486 $677,000
Q1 2023

May 15, 2023
BUY
$4.89 - $12.27 $800,669 - $2.01 Million
163,736 New
163,736 $803,000
Q2 2022

Aug 15, 2022
BUY
$7.45 - $13.84 $29,613 - $55,014
3,975 Added 3.01%
136,026 $1.24 Million
Q1 2022

May 16, 2022
BUY
$9.94 - $12.65 $450,888 - $573,816
45,361 Added 52.33%
132,051 $1.6 Million
Q4 2021

Feb 14, 2022
SELL
$11.99 - $18.14 $762,240 - $1.15 Million
-63,573 Reduced 42.31%
86,690 $1.06 Million
Q3 2021

Nov 15, 2021
BUY
$11.55 - $16.06 $935,711 - $1.3 Million
81,014 Added 116.99%
150,263 $2.32 Million
Q2 2021

Aug 16, 2021
SELL
$12.38 - $29.19 $4.71 Million - $11.1 Million
-380,436 Reduced 84.6%
69,249 $988,000
Q1 2021

May 17, 2021
BUY
$15.07 - $21.71 $2.79 Million - $4.02 Million
185,135 Added 69.98%
449,685 $9.76 Million
Q4 2020

Feb 16, 2021
SELL
$12.72 - $16.16 $1.11 Million - $1.41 Million
-87,168 Reduced 24.78%
264,550 $4 Million
Q3 2020

Nov 16, 2020
BUY
$12.34 - $17.92 $1.44 Million - $2.09 Million
116,380 Added 49.45%
351,718 $4.48 Million
Q2 2020

Aug 14, 2020
BUY
$12.39 - $17.33 $2.14 Million - $3 Million
172,897 Added 276.9%
235,338 $4.02 Million
Q1 2020

May 15, 2020
SELL
$9.12 - $17.78 $384,079 - $748,786
-42,114 Reduced 40.28%
62,441 $825,000
Q4 2019

Feb 14, 2020
BUY
$16.11 - $25.98 $1.68 Million - $2.72 Million
104,555 New
104,555 $1.68 Million
Q1 2019

May 15, 2019
SELL
$14.41 - $19.64 $1.75 Million - $2.38 Million
-121,350 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$12.45 - $23.47 $1.51 Million - $2.85 Million
121,350 New
121,350 $1.58 Million

Others Institutions Holding CARA

# of Institutions
102
Shares Held
21.5M
Call Options Held
50K
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $17.7M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email